Cargando…
Antipsychotic-Induced Insulin Resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease
Atypical antipsychotic (AAP) medications that have revolutionized the treatment of mental illness have become stigmatized by metabolic side effects, including obesity and diabetes. It remains controversial whether the defects are treatment induced or disease related. Although the mechanisms underlyi...
Autores principales: | Teff, Karen L., Rickels, Michael R., Grudziak, Joanna, Fuller, Carissa, Nguyen, Huong-Lan, Rickels, Karl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749337/ https://www.ncbi.nlm.nih.gov/pubmed/23835329 http://dx.doi.org/10.2337/db13-0430 |
Ejemplares similares
-
Restoration of Glucose Counterregulation by Islet Transplantation in Long-standing Type 1 Diabetes
por: Rickels, Michael R., et al.
Publicado: (2015) -
Consumer Advertising Can Be Misleading
por: Rickels, Karl
Publicado: (2006) -
Effect of Exenatide, Sitagliptin, or Glimepiride on β-Cell Secretory Capacity in Early Type 2 Diabetes
por: Gudipaty, Lalitha, et al.
Publicado: (2014) -
Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain
por: Grajales, Diana, et al.
Publicado: (2019) -
Stem Cell–Derived Islets: Next Steps for Histologic and Functional Assessment During Development as a Cellular Therapy for the Treatment of Diabetes
por: Rickels, Michael R.
Publicado: (2019)